Search Results

Bayer’s Kidney Disease Drug Kerendia Reduces Cardiovascular Risk by 16%

Bayer’s Kerendia, at the center of a $3 billion sales forecast, reduced the risk of cardiovascular death and heart failure in a Phase III trial.

September 3, 2024

·

2 min read

·

Annalee Armstrong

Layoffs

Bayer to Lay Off 150 in Basel, Switzerland

The Switzerland layoffs are the latest in Bayer’s 2024 workforce reductions, which already include 1,500 people and nearly half of the executive leadership team.

August 26, 2024

·

1 min read

·

Angela Gabriel

Trendy halftone collage of business concept. Money making concept. Trendy modern retro illustration. Vector illustration of business, contract approval, finance, marketing materials. Vector illustration

Startups

Roivant Creates New ‘Vant’ to License Bayer’s Pulmonary Hypertension Drug

Under an in-license agreement worth up to $294 million, Roivant Sciences gains exclusive worldwide rights from Bayer to develop and commercialize mosliciguat, a potential first-in-class inhaled soluble guanylate cyclase activator.

September 10, 2024

·

2 min read

·

Tristan Manalac

Group Of Employees Being Fired By Their Company.

Layoffs

Bayer, J&J and Pfizer to Lay Off Nearly 500 Combined Employees

Big Pharma companies Bayer and Johnson & Johnson are downsizing their New Jersey workforces while Pfizer cuts jobs in Ireland. Many of the layoffs are effective by the end of the year.

October 2, 2024

·

3 min read

·

Angela Gabriel

Pictured: Bayer's global pharmaceuticals headquarters in Germany

Drug Development

Bayer’s Finerenone Hits Primary Endpoint in Phase III Heart Failure Trial

With the late-stage win, Bayer announced Monday that it plans to talk to regulators about seeking approval in an indication that is central to its $3 billion-plus peak sales forecast.

August 5, 2024

·

2 min read

·

Nick Paul Taylor

Earnings

Bayer Touts ‘Modest’ Q2 Performance Amid Sweeping Reorganization

Bayer’s surprising growth in the second quarter was driven in large part by two pharma products: the prostate cancer drug Nubeqa and the chronic kidney disease treatment Kerendia.

August 6, 2024

·

2 min read

·

Tristan Manalac

Bayer and Google Cloud to Accelerate Development of AI-powered Healthcare Applications for Radiologists

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence solutions to support radiologists and ultimately better serve patients.

April 9, 2024

·

6 min read

Business

Bayer and Rad AI Announce Collaboration agreement

As experts from around the globe gather at the annual Society for Informatics in Medicine conference, Bayer and Rad AI are announcing a collaboration to bring Rad AI’s cutting edge AI radiology operational solutions to Calantic ™ Digital Solution customers.

June 27, 2024

·

5 min read

Bayer’s New Strategy, Novo Vs. Lilly and Psychedelics

Mass layoffs represent a step for Bayer toward reducing managerial layers, while clinical results released in the last week could influence the parallel races between Novo Nordisk and Eli Lilly in the GLP-1 and insulin spaces.

May 21, 2024

·

1 min read

·

Greg Slabodkin, Heather McKenzie, Tyler Patchen

Business

Bayer’s 1,500 Layoffs Are Latest Salvo in CEO Bill Anderson’s Company Overhaul

Since taking the helm in 2023, Anderson has embarked on a radical departure from the traditional structure of large pharma companies. Will getting rid of management layers fix Bayer?

May 17, 2024

·

3 min read

·

Greg Slabodkin